NCT01358383View on ClinicalTrials.gov

Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Juvenile Idiopathic Arthritis

Interventions

DRUG

naproxen

250mg, oral dose

DRUG

esomeprazole

20mg, oral dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY